215 related articles for article (PubMed ID: 30771261)
1. New treatment options for delta virus: Is a cure in sight?
Yurdaydin C
J Viral Hepat; 2019 Jun; 26(6):618-626. PubMed ID: 30771261
[TBL] [Abstract][Full Text] [Related]
2. Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta.
Deterding K; Wedemeyer H
AIDS Rev; 2019; 21(3):126-134. PubMed ID: 31532397
[TBL] [Abstract][Full Text] [Related]
3. Emerging concepts for the treatment of hepatitis delta.
Elazar M; Glenn JS
Curr Opin Virol; 2017 Jun; 24():55-59. PubMed ID: 28475945
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hepatitis D: an unmet medical need.
Caviglia GP; Rizzetto M
Clin Microbiol Infect; 2020 Jul; 26(7):824-827. PubMed ID: 32120043
[TBL] [Abstract][Full Text] [Related]
5. HBV/HDV Coinfection: A Challenge for Therapeutics.
Koh C; Da BL; Glenn JS
Clin Liver Dis; 2019 Aug; 23(3):557-572. PubMed ID: 31266627
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options.
Lempp FA; Ni Y; Urban S
Nat Rev Gastroenterol Hepatol; 2016 Oct; 13(10):580-9. PubMed ID: 27534692
[TBL] [Abstract][Full Text] [Related]
8. Investigational drugs in development for Hepatitis D.
Rizzetto M
Expert Opin Investig Drugs; 2017 Sep; 26(9):999-1005. PubMed ID: 28730878
[TBL] [Abstract][Full Text] [Related]
9. Emerging drugs for hepatitis D.
Keskin O; Yurdaydin C
Expert Opin Emerg Drugs; 2023 Dec; 28(2):55-66. PubMed ID: 37096555
[TBL] [Abstract][Full Text] [Related]
10. Medical Advances in Hepatitis D Therapy: Molecular Targets.
Vogt A; Wohlfart S; Urban S; Mier W
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142728
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis D - how is the fight against this foe going?
Loglio A; Segato S; Lampertico P
Expert Rev Clin Pharmacol; 2019 Mar; 12(3):169-171. PubMed ID: 30698044
[No Abstract] [Full Text] [Related]
12. Hepatitis D Virus and HBsAg Dynamics in the era of new Antiviral Treatments.
Shekhtman L; Duehren S; Etzion O; Cotler SJ; Dahari H
Curr Gastroenterol Rep; 2023 Dec; 25(12):401-412. PubMed ID: 37819559
[TBL] [Abstract][Full Text] [Related]
13. [Is there hope for hepatitis delta ?].
Guglielmi S; Frossard JL; Negro F
Rev Med Suisse; 2016 Aug; 12(528):1415-1418. PubMed ID: 28675280
[TBL] [Abstract][Full Text] [Related]
14. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.
Winer BY; Shirvani-Dastgerdi E; Bram Y; Sellau J; Low BE; Johnson H; Huang T; Hrebikova G; Heller B; Sharon Y; Giersch K; Gerges S; Seneca K; Pais MA; Frankel AS; Chiriboga L; Cullen J; Nahass RG; Lutgehetmann M; Toettcher JE; Wiles MV; Schwartz RE; Ploss A
Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950446
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis D revival.
Wedemeyer H
Liver Int; 2011 Jan; 31 Suppl 1():140-4. PubMed ID: 21205152
[TBL] [Abstract][Full Text] [Related]
16. [Chronic hepatitis B and D (delta) : Current and future treatments].
Wortmann N; Höner Zu Siederdissen C; Cornberg M
Internist (Berl); 2018 Jun; 59(6):519-527. PubMed ID: 29761292
[TBL] [Abstract][Full Text] [Related]
17. Management of hepatitis delta: Need for novel therapeutic options.
Abbas Z; Abbas M
World J Gastroenterol; 2015 Aug; 21(32):9461-5. PubMed ID: 26327754
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection.
Vaillant A
Antiviral Res; 2016 Sep; 133():32-40. PubMed ID: 27400989
[TBL] [Abstract][Full Text] [Related]
19. New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection.
Sandmann L; Wedemeyer H
Clin Liver Dis; 2021 Nov; 25(4):831-839. PubMed ID: 34593156
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of and New Therapies for Hepatitis D.
Koh C; Heller T; Glenn JS
Gastroenterology; 2019 Jan; 156(2):461-476.e1. PubMed ID: 30342879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
